Cost-Effectiveness of Switching to Exemestane (Ex) After 2-3 Years of Adjuvant Tamoxifen (T) in Postmenopausal (Pm) Early Breast Cancer (Ebc)
AuthID
P-004-BA1
P-004-BA1
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service